Freenome is a platform that helps design healthy conditions for an individual based on his/her cell-free genome

Freenome is a health technology company developing accurate, accessible and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. Freenome aims to reinvent disease management through systematized early detection and intervention. Since launching in 2014, the company has raised more than $70 million from leading technology and healthcare investors.

Founders:  Charles Roberts, Gabriel Otte, Michael Otte, Riley Ennis